Powered by

Pulse Biosciences begins rights offering of USD45m common stock

Nov 20, 2018 - Global Banking News

Medical therapy company Pulse Biosciences Inc (Nasdaq:PLSE) reported on Monday the launch of USD45m of its common stock under its rights offering.

The company added the subscription rights will expire and have no value if they are not exercised prior to 17:00 Eastern Time on 6 December 2018 (the expiration date).

At no charge, the company is distributing to the holders of its common stock, non-transferable subscription rights to purchase up to USD45m of its common stock at a subscrip...